Peptidase Inhibitors as a Possible Therapeutic Strategy for Chagas Disease

By  

Current Enzyme Inhibition, Vol. 6, Iss. 4, 2010-01 ,pp. : 183-194

Bentham Science Publishers

Access to resources Recommend Favorite

Implications and consequences of enzyme induction on preclinical and clinical drug development

By Worboys P. D.   Carlile D. J.  

Xenobiotica, Vol. 31, Iss. 8-9, 2001-08 ,pp. : 539-556

Informa Healthcare

Access to resources Recommend Favorite

Carbonic Anhydrase Inhibitors: X-ray Crystallographic Structure of the Adduct of Human Isozyme II with the Perfluorobenzoyl Analogue of Methazolamide. Implications for the Drug Design of Fluorinated Inhibitors

By Abbate Francesco   Casini Angela   Scozzafava Andrea   Supuran Claudiu T.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 18, Iss. 4, 2003-01 ,pp. : 303-308

Informa Healthcare

Access to resources Recommend Favorite

The Binding Energetics of First- and Second-Generation HIV-1 Protease Inhibitors: Implications for Drug Design

By Velazquez-Campoy A.   Kiso Y.   Freire E.  

Archives of Biochemistry and Biophysics, Vol. 390, Iss. 2, 2001-06 ,pp. : 169-175

Elsevier

Access to resources Recommend Favorite

D-Aspartic Acid Localization during Postnatal Development of Rat Adrenal Gland

By Sakai K.   Homma H.   Lee J.A.   Fukushima T.   Santa T.   Tashiro K.   Iwatsubo T.   Imai K.  

Biochemical and Biophysical Research Communications, Vol. 235, Iss. 2, 1997-06 ,pp. : 433-436

Elsevier

Access to resources Recommend Favorite